• No results found

Adenosine diphosphate

Synthesis of DNA and Poly(Adenosine Diphosphate Ribose) in Normal and Chronic Lymphocytic Leukemia Lymphocytes

Synthesis of DNA and Poly(Adenosine Diphosphate Ribose) in Normal and Chronic Lymphocytic Leukemia Lymphocytes

... poly-(adenosine diphosphate ribose) (poly[ADPR]) immediately after isolation and on successive days following their treatment with phytohemagglutinin ...

9

A General Approach Towards Triazole-Linked Adenosine Diphosphate Ribosylated Peptides and Proteins

A General Approach Towards Triazole-Linked Adenosine Diphosphate Ribosylated Peptides and Proteins

... called adenosine diphosphate ribose (ADPr), a modification in which a specific nucleophilic side chain in the target protein displaces β-oriented nicotinamide from NAD ...

5

Biochemical energetics of simulated platelet plug formation: Effect of thrombin, adenosine diphosphate, and epinephrine on intra  and extracellular adenine nucleotide kinetics

Biochemical energetics of simulated platelet plug formation: Effect of thrombin, adenosine diphosphate, and epinephrine on intra and extracellular adenine nucleotide kinetics

... Washed human platelets were incubated in a modified Ringer's solution, pH 7.1, at 37°C for 1 hr. Intracellular basal levels for glycogen, adenosine triphosphate (ATP), adenosine diphosphate (ADP), ...

12

Effect of the effluent released from the canine internal mammary artery after intraluminal and extraluminal perfusion of acetylcholine and adenosine diphosphate

Effect of the effluent released from the canine internal mammary artery after intraluminal and extraluminal perfusion of acetylcholine and adenosine diphosphate

... Even though some authors have demonstrated that cer- tain agonists induce the release of EDRF only by binding to endothelium side receptors [1,3-5], others have dem- onstrated inhibitory mediators released by agonists ...

6

Human autoantibodies to poly(adenosine diphosphate ribose) polymerase

Human autoantibodies to poly(adenosine diphosphate ribose) polymerase

... Acetone-fixed HEp-2 cells Bion Enterprises, Ltd., Park Ridge, IL were reacted with either a serum containing antibodies to ADPRP or affinity purified anti-ADPRP IgG, and followed by fluo[r] ...

6

Journal of Applied Pharmaceutical Science

Journal of Applied Pharmaceutical Science

... Fig. 3: Effect of the different concentrations of Linga Mathirai (LM) on percentage of aggregation formed on rat platelets induced by Thrombin and Adenosine diphosphate (ADP) compared to normal saline and ...

5

Adenine nucleotides and 5 hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery

Adenine nucleotides and 5 hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery

... Micromolar concentrations of adenosine diphosphate, adenosine triphosphate, and 5- hydroxytryptamine were released by platelets under these experimental conditions. The reduced response to electrical ...

8

Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients

Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients

... ADP: Adenosine diphosphate; AR: Aspirin resistance; AS: Aspirin sensitive; ASR: Aspirin semi-resistance; CI: Confidence interval; COX: Cyclooxygenase; END: Early neurological deterioration; ERIS: Early ...

9

Mean Platelet Volume in Acute Myocardial Infarction

Mean Platelet Volume in Acute Myocardial Infarction

... APPENDIX III ABBREVIATIONS AND ACRONYMS ADP - Adenosine diphosphate AWMI - Anterior Wall Myocardial Infarction BP - Blood Pressure CAD - Coronary Artery Disease IWMI - Inferior Wall Myoc[r] ...

103

Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]

Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]

... and the incidence of major vascular events in patients with a wide variety of vascular occlusive pathologies [3]. Their beneficial effects must be, however, balanced against the associated risk of bleeding. ...

6

The Role of Liquid Membrane Phenomenon in Antiplatelet Aggregation of Quercetin 3 O Fatty Acid Esters

The Role of Liquid Membrane Phenomenon in Antiplatelet Aggregation of Quercetin 3 O Fatty Acid Esters

... inducer, adenosine diphosphate and the calcium ion across the liquid membrane formed by quercetin-3-O-fatty acid esters and quercetin-3-O-fatty acid esters with L-α-phosphatidylcholine-cholesterol was ...of ...

10

The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

... Mg-ADP: Magnesium adenosine diphosphate; MMA: Middle meningeal artery; NBD: Nucleotide binding domains; NO: Nitric oxide; PACAP: Pituitary adenylate cyclase activating polypeptide; PGI2:[r] ...

9

In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits

In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits

... To assess platelet function, Agg RAM aggregometer (Helena Biosciences, Europe) was used, manufacturer in- structions were followed. Blood was taken in the ratio of 9:1 v/v in trisodium citrate (3.8%). This analysis is ...

8

Viscum album L. & Abies alba borisii regis effects on platelet aggregation and tumor metastasis

Viscum album L. & Abies alba borisii regis effects on platelet aggregation and tumor metastasis

... [adenosine diphosphate (ADP), platelet- activating factor (PAF), and arachidonic acid (ARA)]. The agonists’ concentration was adjusted to cause maximum, irreversible accumulation in control platelets. Apart ...

7

Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.

Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.

... poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors, where early studies of olaparib showed response rates of 69% in those with platinum-sensitive disease, compared with 45% and 23% in the ...

14

Activation of ATPase activity of simian virus 40 large T antigen by the covalent affinity analog of ATP, fluorosulfonylbenzoyl 5'-adenosine.

Activation of ATPase activity of simian virus 40 large T antigen by the covalent affinity analog of ATP, fluorosulfonylbenzoyl 5'-adenosine.

... A second form of T was initially inactive as an ATPase, and binding of FSBA or Mg-ATP or Mg-AMPPCP [AMPPCP is -y1-methylene 5' adenosine diphosphate] resulted in the It is known that the[r] ...

9

Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support

Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support

... ADP: Adenosine diphosphate; aPTT: Activated partial thromboplastin time; AT: Anti-thrombin; B: Baseline; CFT: Clot formation time; CT: Clotting time; ECMO: Extracorporeal membrane oxygenation; FBE: Full ...

9

Cell-Penetrating And Antibacterial BUF-II Nanobioconjugates: Enhanced Potency Via Immobilization On Polyetheramine-Modified Magnetite Nanoparticles

<p>Cell-Penetrating And Antibacterial BUF-II Nanobioconjugates: Enhanced Potency Via Immobilization On Polyetheramine-Modified Magnetite Nanoparticles</p>

... ( C ) Platelet aggregation caused by bare magnetite (blue), PEA-coated magnetite nanoparticles (red) and BUF-II-PEA-magnetite nanobioconjugates (green) compared to Adenosine diphosphate [r] ...

15

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention

... = adenosine diphosphate; AMI = acute myocardial infarction; BAAS = Balloon Angioplasty and Anticoagulation Study; CAPTURE = c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina; CI = confidence ...

12

Heterogeneity of human platelets: II  Functional evidence suggestive of young and old platelets

Heterogeneity of human platelets: II Functional evidence suggestive of young and old platelets

... of adenosine diphosphate (ADP), thrombin, or epinephrine, platelet aggregation time was ...greater adenosine triphosphate (ATP) into the medium, respectively, than did light- small ...

6

Show all 1254 documents...

Related subjects